2810
C. Mayato et al. / Tetrahedron: Asymmetry 18 (2007) 2803–2811
9.5 Hz, H-5), 4.53 (dd, J = 3.8 and 12.1 Hz, H-1proS), 4.50
(dd, J = 5.3 and 12.1 Hz, H-1proR), 4.35 (ddd, J = 4.0, 5.8,
and 9.6 Hz, H-6), 4.22 (ddd, J = 3.8, 5.3, and 9.2 Hz, H-2),
2.03 (ddddd, J = 7.3, 7.3, 7.3, 9.6, and 14.5 Hz, H-7proS),
1.71 (ddddd, J = 4.0, 7.3, 7.3, 7.3, and 14.5 Hz, H-7proR),
1.02 (t, J = 7.3 Hz, 3H); 13C NMR (CDCl3) d 165.4 (s),
165.1 (s), 164.5 (s), 164.5 (s), 131.9–131.1, 128.9 (s), 128.9
(s), 128.8 (s), 128.4 (s), 128.4 (s), 127.7 (s), 127.6 (s),
127.6 (s), 74.1 (d, C-6), 71.5 (d, C-5), 70.9 (d, C-4), 70.0
(d, C-3), 68.8 (d, C-2), 63.5 (t, C-1), 18.8 (t, C-7), 9.4 (q,
C-8); UV (CH3CN) kmax 245 nm; CD (CH3CN) kext (De)
251 nm (11.7), 234 nm (À4.3); Anal. Calcd for
C36H28Br4O9: C, 46.78; H, 3.05. Found: C, 46.81; H, 3.00.
131.2, 128.9 (s), 128.9 (s), 128.8 (s), 128.4 (s), 128.4 (s),
127.8 (s), 127.6 (s), 127.5 (s), 71.5 (d, C-5), 71.2 (d, C-6),
71.0 (d, C-4), 70.1 (d, C-3), 69.0 (d, C-2), 63.6 (t, C-1),
33.9 (t, C-7), 24.2 (d, C-8), 23.5 (q), 21.3 (q); UV (CH3CN)
kmax 245 nm; CD (CH3CN) kext (De) 251 nm (8.5), 234 nm
(À3.5); Anal. Calcd for C38H32Br4O9: C, 47.93; H, 3.39.
Found: C, 48.03; H, 3.43.
4.14. 2,6-Anhydro-1,3,4,5-tetra-O-(p-bromobenzoyl)-7-
cyclohexyl-7-deoxy-D-glycero-L-gulo-heptitol 2e
Debenzylation of compound 1e (75 mg, 0.14 mmol) and
then p-bromobenzoylation, performed as in the general
procedure, led to compound 2e (134 mg, 0.14 mmol, 96%)
after column chromatography (n-hexane/EtOAc, 9:1):
TLC Rf = 0.3 (n-hexane/EtOAc, 9:1); [a]D = +26.7 (c 0.8,
CHCl3); 1H NMR (CDCl3) d 7.90 (d, J = 8.5 Hz, 2H),
7.79 (d, J = 8.5 Hz, 2H), 7.76 (d, J = 8.6 Hz, 2H), 7.72
(d, J = 8.6 Hz, 2H), 7.56 (d, J = 8.5 Hz, 2H), 7.54 (d,
J = 8.6 Hz, 2H), 7.49 (d, J = 8.6 Hz, 2H), 7.47 (d,
J = 8.6 Hz, 2H), 5.92 (t, J = 9.4 Hz, H-4), 5.48 (t,
J = 9.2 Hz, H-3), 5.45 (dd, J = 5.8 and 9.7 Hz, H-5), 4.58
(ddd, J = 3.1, 5.8, and 8.9 Hz, H-6), 4.51 (dd, J = 3.1 and
12.0 Hz, H-1proS), 4.46 (dd, J = 6.1 and 12.0 Hz, H-1proR),
4.25 (ddd, J = 3.1, 6.1, and 9.3 Hz, H-2), 1.98 (ddd,
J = 3.6, 8.9, and 14.9 Hz, H-7proS), 1.77 (m, 2H), 1.68–
1.53 (m, 3H), 1.48 (m, 1H), 1.37 (ddd, J = 3.1, 9.5, and
14.9 Hz, H-7proR), 1.15–0.97 (m, 4H), 0.83 (m, 1H); 13C
NMR (CDCl3) 165.3 (s), 165.1 (s), 164.5 (s), 164.5 (s),
131.9–131.1, 128.9 (s), 128.8 (s), 128.7 (s), 128.4 (s), 128.4
(s), 127.7 (s), 127.6 (s), 127.5 (s), 71.5 (d, C-5), 70.9 (d,
C-4), 70.6 (d, C-6), 70.1 (d, C-3), 68.9 (d, C-2), 63.7 (t,
C-1), 34.1 (t, C-7), 33.4 (d), 32.5 (t), 32.0 (t), 26.3 (t),
26.3 (t), 25.9 (t); UV (CH3CN) kmax 245 nm; CD (CH3CN)
kext (De) 251 nm (4.8), 234 nm (À2.7); Anal. Calcd
for C41H36Br4O9: C, 49.62; H, 3.66. Found: C, 49.59; H,
3.74.
4.12. 2,6-Anhydro-1,3,4,5-tetra-O-(p-bromobenzoyl)-7,8,9-
trideoxy-D-glycero-L-gulo-nontitol 2c
Debenzylation of compound 1c (156 mg, 0.33 mmol) and
then p-bromobenzoylation, performed as in the general
procedure, led to compound 2c (303 mg, 0.32 mmol, 99%)
after column chromatography (n-hexane/EtOAc, 9:1):
TLC Rf = 0.5 (n-hexane/EtOAc, 8:2); [a]D = +37.5 (c 1.0,
CHCl3); 1H NMR (CDCl3) d 7.87 (d, J = 8.6 Hz, 2H),
7.80 (d, J = 8.6 Hz, 2H), 7.74 (d, J = 8.5 Hz, 2H), 7.72
(d, J = 8.5 Hz, 2H), 7.56 (d, J = 8.6 Hz, 2H), 7.54 (d,
J = 8.6 Hz, 2H), 7.49 (d, J = 8.6 Hz, 2H), 7.47 (d,
J = 8.6 Hz, 2H), 5.92 (t, J = 9.3 Hz, H-4), 5.51 (t,
J = 9.2 Hz, H-3), 5.47 (dd, J = 5.8 and 9.6 Hz, H-5), 4.52
(dd, J = 3.8 and 12.1 Hz, H-1proS), 4.49 (dd, J = 5.4 and
12.1 Hz, H-1proR), 4.45 (ddd, J = 3.5, 5.8, and 9.2 Hz,
H-6), 4.23 (ddd, J = 3.8, 5.4, and 9.2 Hz, H-2), 2.02 (m,
H-7proS), 1.60–1.50 (m, 2H), 1.38 (m, H-8), 0.96 (t,
J = 7.2 Hz, 3H); 13C NMR (CDCl3) d 165.4 (s), 165.1 (s),
164.6 (s), 164.6 (s), 132.0–131.2, 128.9 (s), 128.9 (s), 128.8
(s), 128.4 (s), 128.4 (s), 127.8 (s), 127.6 (s), 127.6 (s), 72.6
(d, C-6), 71.5 (d, C-5), 70.9 (d, C-4), 70.0 (d, C-3), 68.9
(d, C-2), 63.5 (t, C-1), 27.5 (t, C-7), 18.2 (t, C-8), 13.7 (q,
C-9); UV (CH3CN) kmax 245 nm; CD (CH3CN) kext (De)
251 nm (10.9), 234 nm (À3.4); Anal. Calcd for
C37H30Br4O9: C, 47.36; H, 3.22. Found: C, 47.40; H, 3.47.
4.15. 2,6-Anhydro-1,3,4,5-tetra-O-(p-bromobenzoyl)-7,8,9-
trideoxy-8,8-dimethyl-D-glycero-L-gulo-nonitol 2f
4.13. 2,6-Anhydro-1,3,4,5-tetra-O-(p-bromobenzoyl)-7,8,9-
trideoxy-8-methyl-D-glycero-L-gulo-nontitol 2d
Debenzylation of compound 1f (384 mg, 0.76 mmol) and
then p-bromobenzoylation, performed as in the general
procedure, gave compound 2f (601 mg, 0.62 mmol, 82%)
after column chromatography (n-hexane/EtOAc, 9:1):
TLC Rf = 0.3 (n-hexane/EtOAc, 9:1); [a]D = +23.6 (c 0.8,
CHCl3); 1H NMR (CDCl3) d 7.85 (d, J = 8.5 Hz, 2H),
7.79 (d, J = 8.5 Hz, 2H), 7.75 (d, J = 8.5 Hz, 2H), 7.71
(d, J = 8.5 Hz, 2H), 7.54 (d, J = 8.5 Hz, 2H), 7.53 (d,
J = 8.5 Hz, 2H), 7.48 (d, J = 8.6 Hz, 2H), 7.46 (d, J =
8.6 Hz, 2H), 5.84 (t, J = 9.4 Hz, H-4), 5.52 (t, J = 9.3 Hz,
H-3), 5.41 (dd, J = 5.9 and 10.1 Hz, H-5), 4.65 (dd,
J = 5.9 and 10.1 Hz, H-6), 4.53 (dd, J = 3.1 and 12.0 Hz,
H-1proS), 4.45 (dd, J = 5.5 and 12.0 Hz, H-1proR), 4.35
(ddd, J = 3.1, 5.5, and 9.3 Hz, H-2), 1.96 (dd, J = 10.1
and 15.0 Hz, H-7proS), 1.48 (d, J = 15.0 Hz, H-7proR),
0.95 (s, 9H); 13C NMR (CDCl3) d 165.4 (s), 165.1 (s),
164.5 (s), 164.5 (s), 132.0–131.1, 128.8 (s), 128.8 (s), 128.7
(s), 128.4 (s), 128.3 (s), 127.7 (s), 127.5 (s), 127.5 (s), 71.5
(d, C-5), 71.2 (d, C-6), 70.8 (d, C-4), 70.1 (d, C-3), 68.7
(d, C-2), 63.7 (t, C-1), 36.9 (t, C-7), 30.4 (s, C-8), 29.6
(q), 29.6 (q), 29.6 (q); UV (CH3CN) kmax 245 nm; CD
Debenzylation of compound 1d (510 mg, 1.04 mmol) and
then p-bromobenzoylation, performed as in the general
procedure, led to compound 2d (955 mg, 1.00 mmol,
96%) after column chromatography (n-hexane/EtOAc,
9:1): TLC Rf = 0.3 (n-hexane/EtOAc, 9:1); [a]D = +32.3
1
(c 1.4, CHCl3); H NMR (CDCl3)d 7.86 (d, J = 8.6 Hz,
2H), 7.80 (d, J = 8.6 Hz, 2H), 7.75 (d, J = 8.6 Hz, 2H),
7.72 (d, J = 8.6 Hz, 2H), 7.56 (d, J = 8.5 Hz, 2H), 7.54
(d, J = 8.5 Hz, 2H), 7.49 (d, J = 8.6 Hz, 2H), 7.47 (d,
J = 8.6 Hz, 2H), 5.92 (t, J = 9.3 Hz, H-4), 5.51 (t,
J = 9.2 Hz, H-3), 5.47 (dd, J = 5.9 and 9.7 Hz, H-5), 4.55
(ddd, J = 3.4, 5.8, and 9.2 Hz, H-6), 4.52 (dd, J = 3.5 and
12.0 Hz, H-1proS), 4.48 (dd, J = 5.5 and 12.0 Hz, H-1proR),
4.23 (ddd, J = 3.5, 5.5, and 9.2 Hz, H-2), 2.03 (ddd,
J = 4.5, 9.2, and 14.7 Hz, H-7proS), 1.80 (m, H-8), 1.35
(ddd, J = 3.4, 9.5, and 14.7 Hz, H-7proR), 0.99 (d,
J = 6.7 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H); 13C NMR
(CDCl3) d 165.4 (s), 165.2 (s), 164.6 (s), 164.6 (s), 132.0–